Trends in COVID-19 Risk-Adjusted Mortality Rates

Leora I Horwitz1,2,3, Simon A Jones1,2, Robert J Cerfolio4

  • 1Center for Healthcare Innovation and Delivery Science, NYU Langone Health, New York, New York.

Insights

COVID-19 (coronavirus disease 2019) mortality has decreased, even when accounting for patient demographics and clinical factors. This study suggests improved outcomes in a New York health system from March to August 2020.

Area of Science:

  • Infectious Diseases
  • Epidemiology
  • Critical Care Medicine

Background:

  • Early phases of the COVID-19 pandemic were associated with high in-hospital mortality rates.
  • Recent observations suggest a decline in COVID-19 mortality, prompting investigation into contributing factors.
  • Changes in patient demographics, including age and comorbidities, may influence observed mortality trends.

Purpose of the Study:

  • To investigate the association between changing patient demographics and hospital mortality during the COVID-19 pandemic.
  • To determine if the decrease in COVID-19 mortality rates is attributable to improved treatments or shifts in patient characteristics.
  • To analyze in-hospital mortality trends adjusted for demographic and clinical factors within an academic health system.

Main Methods:

  • Retrospective analysis of 5,121 hospitalizations for COVID-19 from March to August 2020 across three hospitals.
  • In-hospital mortality or discharge to hospice was the primary outcome measure.
  • Statistical adjustment for demographic factors, comorbidities, admission vital signs, and laboratory results was performed.

Main Results:

  • Adjusted in-hospital mortality for COVID-19 decreased significantly from 25.6% in March to 7.6% in August 2020.
  • The standardized mortality ratio declined from 1.26 in March to 0.38 in August, indicating a substantial reduction in observed versus expected deaths.
  • The average probability of death decreased by 18.2 percentage points from March to August, after accounting for patient characteristics.

Conclusions:

  • COVID-19 hospital mortality has demonstrably decreased within this academic health system.
  • The observed reduction in mortality persists even after adjusting for changes in patient demographics and clinical profiles.
  • These findings suggest a genuine improvement in COVID-19 outcomes over time, independent of patient population shifts.

Related Concept Videos

Relative Risk01:12

Relative Risk

Relative risk (RR) is a statistical measure commonly used in epidemiology to compare the likelihood of a particular event occurring between two groups. This metric is important for evaluating the relationship between exposure to a specific risk factor and the probability of a particular outcome. It plays a crucial role in medical research, public health studies, and risk assessment. Relative risk quantifies how much more (or less) likely an event is to occur in an exposed group compared to an...
1.4K
Factors Affecting the Risk of Infection01:26

Factors Affecting the Risk of Infection

The hosts' susceptibility to infection depends on several factors. The integrity of the skin and mucous membranes helps protect the body against microbial attacks. When the skin is altered, the chance of infection, limb loss, and even death increases.
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin...
13.1K
Actuarial Approach01:20

Actuarial Approach

The actuarial approach, a statistical method originally developed for life insurance risk assessment, is widely used to calculate survival rates in clinical and population studies. This method accounts for participants lost to follow-up or those who die from causes unrelated to the study, ensuring a more accurate representation of survival probabilities.
Consider the example of a high-risk surgical procedure with significant early-stage mortality. A two-year clinical study is conducted,...
211
Bias in Epidemiological Studies01:29

Bias in Epidemiological Studies

Biases can arise at various stages of research, from study design and data collection to analysis and interpretation. Recognizing and addressing these biases is essential to ensure the validity and reliability of epidemiological findings.Broadly speaking, biases in epidemiology fall into three main categories: selection bias, information bias, and confounding. A more detailed description of possible biases is:  
1.0K
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
283
Factors Affecting Illness01:18

Factors Affecting Illness

When a person's physical, emotional, intellectual, social development or spiritual functioning is compromised, this deviation from a healthy normal state is called illness. Illness creates stress that in turn harms individuals. Irritation, anger, denial, hopelessness, and fear are behavioral and emotional changes an individual experiences in the phases of illness. A variety of factors influence a person's health and well-being.
For instance, risk factors are connected to illness,...
4.8K